Novo Nordisk has slashed prices of its blockbuster diabetes and weight loss drugs Ozempic and Wegovy in India by up to 36 percent and 48 percent respectively, as a wave of lower priced generics enters ...

The job market has drawn a lot of attention over the past two weeks. Putting aside the political discourse over the Bureau of Labor Statistics, the agency’s most-recent numbers reflect an employment ...

Job interviews are crucial moments in your career journey, where you have the opportunity to impress potential employers and ...

It is Guthrie's first interview since her mom, Nancy, went missing nearly two months ago. By Tony Maglio Savannah Guthrie is returning to NBC’s Today show via a lengthy prerecorded interview with her ...

Novo Nordisk AS has slashed prices of its blockbuster weight-loss drugs Ozempic and Wegovy in India, amid an onslaught of copycat drugs in the world's third most overweight population. Many patients ...

Before Savannah Guthrie returns to “Today,” she’s going to be the subject of one of the show’s biggest stories. Guthrie will take part in a two-part interview with Hoda Kotb during which she is ...

India's pharma industry is ready to flex its generics muscle as the patent for a key ingredient of blockbuster weight-loss drugs expires today. Pharmarack estimates India’s weight-loss drug market to ...

Add Yahoo as a preferred source to see more of our stories on Google. President Donald Trump put a move on Fox News host Dana Perino smack dab in the middle of a round-robin interview on the horrors ...

With patents expiring today in India for Novo Nordisk’s popular diabetes and obesity drugs Ozempic and Wegovy, more than 40 generic drug makers are expected to begin launching their cheaper versions ...

In an exclusive interview with Meet the Press, Treasury Secretary Scott Bessent discusses the Trump Administration’s decision to remove sanctions on Iranian oil and ...